These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 25309068)
1. Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods. Marengo E; Robotti E World J Gastroenterol; 2014 Oct; 20(37):13325-42. PubMed ID: 25309068 [TBL] [Abstract][Full Text] [Related]
2. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786 [TBL] [Abstract][Full Text] [Related]
3. Understanding the Conundrum of Pancreatic Cancer in the Omics Sciences Era. Nicoletti A; Paratore M; Vitale F; Negri M; Quero G; Esposto G; Mignini I; Alfieri S; Gasbarrini A; Zocco MA; Zileri Dal Verme L Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062863 [TBL] [Abstract][Full Text] [Related]
4. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis. Jia Y; Shen M; Zhou Y; Liu H Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517 [TBL] [Abstract][Full Text] [Related]
5. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics. Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548 [TBL] [Abstract][Full Text] [Related]
6. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis. Luo X; Liu J; Wang H; Lu H Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036 [TBL] [Abstract][Full Text] [Related]
7. Development of a classification and ranking method for the identification of possible biomarkers in two-dimensional gel-electrophoresis based on principal component analysis and variable selection procedures. Robotti E; Demartini M; Gosetti F; Calabrese G; Marengo E Mol Biosyst; 2011 Mar; 7(3):677-86. PubMed ID: 21286649 [TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling of pancreatic cancer for biomarker discovery. Chen R; Pan S; Brentnall TA; Aebersold R Mol Cell Proteomics; 2005 Apr; 4(4):523-33. PubMed ID: 15684406 [TBL] [Abstract][Full Text] [Related]
9. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma. Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415 [TBL] [Abstract][Full Text] [Related]
10. Strategies for discovering novel pancreatic cancer biomarkers. Chan A; Diamandis EP; Blasutig IM J Proteomics; 2013 Apr; 81():126-34. PubMed ID: 23026552 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer. Vandenbrouck Y; Christiany D; Combes F; Loux V; Brun V Proteomics; 2019 Nov; 19(21-22):e1800489. PubMed ID: 31538697 [TBL] [Abstract][Full Text] [Related]
12. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes. Hernández-Vargas P; Muñoz M; Domínguez F Hum Reprod Update; 2020 Feb; 26(2):264-301. PubMed ID: 32096829 [TBL] [Abstract][Full Text] [Related]
13. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781 [TBL] [Abstract][Full Text] [Related]
14. Early detection of pancreatic cancer: Where are we now and where are we going? Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774 [TBL] [Abstract][Full Text] [Related]
15. Circulating RNAs as new biomarkers for detecting pancreatic cancer. Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396 [TBL] [Abstract][Full Text] [Related]
16. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer. Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959 [TBL] [Abstract][Full Text] [Related]
17. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916 [TBL] [Abstract][Full Text] [Related]
18. Proteomic and genomic profiling of pancreatic cancer. Ansari D; Torén W; Zhou Q; Hu D; Andersson R Cell Biol Toxicol; 2019 Aug; 35(4):333-343. PubMed ID: 30771135 [TBL] [Abstract][Full Text] [Related]
19. New developments in the early diagnosis of pancreatic cancer. Zhang Q; Chen S; Zeng L; Chen Y; Lian G; Qian C; Li J; Xie R; Huang KH Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):149-156. PubMed ID: 27937041 [TBL] [Abstract][Full Text] [Related]